Literature DB >> 19617865

Congenital anomalies and resource utilization in neonates infected with herpes simplex virus.

Lilliam Ambroggio1, Scott A Lorch, Zeinab Mohamad, Jana Mossey, Samir S Shah.   

Abstract

BACKGROUND: Neonatal herpes simplex virus (HSV) infection, while uncommon, is associated with substantial morbidity and mortality. However, there is little nationally representative data describing resource utilization.
METHODS: This retrospective cohort study was conducted using the Pediatric Health Information System, an administrative database that contains discharge diagnosis and resource utilization data from 35 free-standing children's hospitals. Patients <or=60 days of age with a primary discharge diagnosis of HSV were study eligible if they received intravenous acyclovir and were discharged between January 1, 2003 and December 31, 2005.
RESULTS: There were 406 patients with HSV. The median age was 16 days (interquartile range: 8-31 days); 52% of patients were female. Congenital heart disease, the most common congenital anomaly, occurred in 10% of patients. The median length of stay was 15 days; 21 (5%) patients died. HSV was associated with substantial resource utilization. The median hospital charge was $37,431 (interquartile range: $14,667-$74,559) per infant. The presence of congenital heart disease independently increased the hospital length of stay by 93% (adjusted LOS ratio: 1.93; 95% CI: 1.5-2.5).
CONCLUSIONS: HSV infection in neonates and young infants was associated with substantial resource utilization. The presence of an underlying congenital cardiac anomaly was associated with a significantly longer length of stay and higher hospital charges.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19617865      PMCID: PMC2783783          DOI: 10.1097/OLQ.0b013e3181aaf54f

Source DB:  PubMed          Journal:  Sex Transm Dis        ISSN: 0148-5717            Impact factor:   2.830


  17 in total

1.  Medical care expenditures for genital herpes in the United States.

Authors:  G Tao; W J Kassler; D B Rein
Journal:  Sex Transm Dis       Date:  2000-01       Impact factor: 2.830

2.  Mortality associated with congenital heart defects in the United States: trends and racial disparities, 1979-1997.

Authors:  R S Boneva; L D Botto; C A Moore; Q Yang; A Correa; J D Erickson
Journal:  Circulation       Date:  2001-05-15       Impact factor: 29.690

3.  Regression analyses of counts and rates: Poisson, overdispersed Poisson, and negative binomial models.

Authors:  W Gardner; E P Mulvey; E C Shaw
Journal:  Psychol Bull       Date:  1995-11       Impact factor: 17.737

Review 4.  The risk of determining risk with multivariable models.

Authors:  J Concato; A R Feinstein; T R Holford
Journal:  Ann Intern Med       Date:  1993-02-01       Impact factor: 25.391

5.  ACOG practice bulletin. Management of herpes in pregnancy. Number 8 October 1999. Clinical management guidelines for obstetrician-gynecologists.

Authors: 
Journal:  Int J Gynaecol Obstet       Date:  2000-02       Impact factor: 3.561

6.  Natural history of neonatal herpes simplex virus infections in the acyclovir era.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L M Frenkel; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

7.  Safety and efficacy of high-dose intravenous acyclovir in the management of neonatal herpes simplex virus infections.

Authors:  D W Kimberlin; C Y Lin; R F Jacobs; D A Powell; L Corey; W C Gruber; M Rathore; J S Bradley; P S Diaz; M Kumar; A M Arvin; K Gutierrez; M Shelton; L B Weiner; J W Sleasman; T M de Sierra; S Weller; S J Soong; J Kiell; F D Lakeman; R J Whitley
Journal:  Pediatrics       Date:  2001-08       Impact factor: 7.124

8.  An appraisal of screening for maternal type-specific herpes simplex virus antibodies to prevent neonatal herpes.

Authors:  D J Rouse; J S Stringer
Journal:  Am J Obstet Gynecol       Date:  2000-08       Impact factor: 8.661

9.  Respiratory syncytial viral infection in infants with congenital heart disease.

Authors:  N E MacDonald; C B Hall; S C Suffin; C Alexson; P J Harris; J A Manning
Journal:  N Engl J Med       Date:  1982-08-12       Impact factor: 91.245

10.  Effect of serologic status and cesarean delivery on transmission rates of herpes simplex virus from mother to infant.

Authors:  Zane A Brown; Anna Wald; R Ashley Morrow; Stacy Selke; Judith Zeh; Lawrence Corey
Journal:  JAMA       Date:  2003-01-08       Impact factor: 56.272

View more
  6 in total

1.  Neonatal Herpes Simplex Virus Infection Among Medicaid-Enrolled Children: 2009-2015.

Authors:  Sanjay Mahant; Matt Hall; Amanda C Schondelmeyer; Jay G Berry; David W Kimberlin; Samir S Shah
Journal:  Pediatrics       Date:  2019-04       Impact factor: 7.124

2.  Evaluation for Neonatal HSV in Infants Undergoing Workup for Serious Bacterial Infection: A 5-Year Retrospective Review.

Authors:  Laura H Brower; Paria M Wilson; Eileen Murtagh-Kurowski; Joshua D Courter; Samir S Shah; Amanda C Schondelmeyer
Journal:  Hosp Pediatr       Date:  2020-05-08

3.  Herpes simplex virus infection in neonates and young infants with sepsis.

Authors:  Saeid Amel Jamehdar; Gholamali Mammouri; Mohammad Reza Sharifi Hoseini; Hosein Nomani; Monavvar Afzalaghaee; Hassan Boskabadi; Mohammad Hassan Aelami
Journal:  Iran Red Crescent Med J       Date:  2014-02-05       Impact factor: 0.611

4.  Healthcare resource utilisation pattern and costs associated with herpes simplex virus diagnosis and management: a systematic review.

Authors:  Shaun Wen Huey Lee; Sami L Gottlieb; Nathorn Chaiyakunapruk
Journal:  BMJ Open       Date:  2022-01-04       Impact factor: 2.692

5.  First estimates of the global and regional incidence of neonatal herpes infection.

Authors:  Katharine J Looker; Amalia S Magaret; Margaret T May; Katherine M E Turner; Peter Vickerman; Lori M Newman; Sami L Gottlieb
Journal:  Lancet Glob Health       Date:  2017-01-31       Impact factor: 26.763

6.  TORCH Antibodies Among Pregnant Women and Their Newborns Receiving Care at Kilimanjaro Christian Medical Centre, Moshi, Tanzania.

Authors:  Aliasgher M Saajan; Mramba Nyindo; Joshua G Gidabayda; Mohammed S Abdallah; Shaneabbas H Jaffer; Aliasgher G Mukhtar; Tima M Khatibu; Rune Philemon; Grace D Kinabo; Blandina T Mmbaga
Journal:  East Afr Health Res J       Date:  2017-07-01
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.